Remove Drugs Remove Pharma Companies Remove White Paper
article thumbnail

Top 10 Drug Discovery Trends at the Top 20 Pharma

PerkinElmer

Industry leaders reveal how high throughput screening is changing in R&D What do you think are the major trends in drug discovery R&D? That is not what PerkinElmer found in a comprehensive survey of leaders at the top 20 Pharma, ranked for R&D spending. A PerkinElmer White Paper offers a detailed look at the findings.

article thumbnail

Nearly half of supply chain leaders are experiencing drug shortages and disruptions due to pandemic and AI challenge aims to restart economies after lockdowns

The Pharma Data

According to a benchmarking survey by TraceLink , 532 global supply chain leaders from various leading pharma companies, wholesale distributors, hospitals and pharmacies have indicated the supply chain has been severely impacted by the Covid-19 pandemic. Save your early bird seat now.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Compliant Science: The Critical Role of Compliance for Medical Affairs

H1 Blog

Anti-kickback laws are federal statutes designed to protect patients from paying more than necessary for medical services or devices by preventing physicians from receiving kickbacks or bribes in exchange for referring patients to certain providers or prescribing certain drugs.

article thumbnail

Keeping tabs on Covid-19: Starpharma creates slow release remdesivir nanoparticl…

The Pharma Data

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.

article thumbnail

Keeping tabs on Covid-19: BetterLife embraces virtual clinical trials and Novan shares positive results from in vitro antiviral technology against SARS-CoV-2

The Pharma Data

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. Download Medidata’s white paper to learn how to virtualize clinical trials and bring new therapies closer to patients.